Retrovectors for Intron-Enhanced Protein Expression

用于内含子增强蛋白质表达的逆向载体

基本信息

  • 批准号:
    6991099
  • 负责人:
  • 金额:
    $ 8.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-01 至 2006-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Retrovectors are widely used for gene transfer in gene therapy, tissue culture and transgenic animals for research or commercial applications.. A long recognized limitation of current retrovectors is that introns are spliced out as retrovector particles are made in packaging cells. Introns may regulate the expression of the genes and convey tissue specificity. The presence of introns boosts expression as a consequence of active splicing. This proposal tests the design of retrovectors which preserve introns by utilizing elements of viral RNA export mechanisms naturally occurring in the complex retroviruses. A packaging cell expressing an RNA export enabling protein (Rex) will be used to produce vectors whose constructs contain the corresponding Rex responsive element (RxRE). In combination this should allow the making of retroviral vectors which contain introns. These vectors subsequently allow the transfer of introncontaining constructs into the final host cell. Relevance: Previously considered "junk DMA", introns are now understood to exert significant effects on the adjacent coding regions of genes. By enabling the transfer of intron-containing genes we anticipate (a) providing a means to make gene therapy vectors with greater predictability of expression and tissue specificity; (b) providing a boost to protein expression in cell culture bioreactor systems and transgenic animals and (c) providing a useful research tool to enhance understanding of RNA biology.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL IMBODEN其他文献

MICHAEL IMBODEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL IMBODEN', 18)}}的其他基金

Antibody-Biocide Fusions to Control Cryptosporidium
抗体-杀菌剂融合来控制隐孢子虫
  • 批准号:
    8118996
  • 财政年份:
    2009
  • 资助金额:
    $ 8.97万
  • 项目类别:
Antibody-Biocide Fusions to Control Cryptosporidium
抗体-杀菌剂融合来控制隐孢子虫
  • 批准号:
    6695088
  • 财政年份:
    2003
  • 资助金额:
    $ 8.97万
  • 项目类别:
Antibody-Biocide Fusions to Control Cryptosporidium
抗体-杀菌剂融合来控制隐孢子虫
  • 批准号:
    7115180
  • 财政年份:
    2003
  • 资助金额:
    $ 8.97万
  • 项目类别:
Antibody-Biocide Fusions to Control Cryptosporidium
抗体-杀菌剂融合来控制隐孢子虫
  • 批准号:
    6785478
  • 财政年份:
    2003
  • 资助金额:
    $ 8.97万
  • 项目类别:
Antibody-Biocide Fusions to Control Cryptosporidium
抗体-杀菌剂融合来控制隐孢子虫
  • 批准号:
    7156172
  • 财政年份:
    2003
  • 资助金额:
    $ 8.97万
  • 项目类别:
Antibody-Biocide Fusions to Control Cryptosporidium
抗体-杀菌剂融合来控制隐孢子虫
  • 批准号:
    7329812
  • 财政年份:
    2003
  • 资助金额:
    $ 8.97万
  • 项目类别:
TRANSGENIC ANTIVIRALS FOR BOVINE LEUKEMIA VIRUS
针对牛白血病病毒的转基因抗病毒药物
  • 批准号:
    6910528
  • 财政年份:
    2000
  • 资助金额:
    $ 8.97万
  • 项目类别:

相似海外基金

Structural Evolution of the Dimer interface in Hepadnaviridae
嗜肝DNA病毒科二聚体界面的结构演化
  • 批准号:
    530369173
  • 财政年份:
  • 资助金额:
    $ 8.97万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了